We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Newly Developed Nitric Oxide-Releasing Polymers Have Potential Medical Applications

By Biotechdaily staff writers
Posted on 26 Apr 2007
A newly developed group of plastics that release nitric oxide (NO)--a molecule that influences body functions ranging from sexual function to communication among nerves--may have broad applications in medicine, according to researchers.

Dr. More...
Joseph A. Hrabie, from the U.S. National Cancer Institute (Frederick, MD, USA), and colleagues at Northwestern University (Evanston, IL, USA) reported synthesis of NO-releasing forms of the most commercially important polyacrylonitrile (PAN) polymers. The new polymers include a textile, a plastic and a rubber.
Their findings were published in an article in the April 4, 2007, issue of the Journal of the American Chemical Society.

Some of the materials continuously release small amounts of NO for months. NO dilates blood vessels and has other bodily actions, suggesting that it could reduce adverse effects such as blood vessel scaring and narrowing that are likely to occur after coronary angioplasty and bypass surgery.

In studies with laboratory rats, the researchers revealed that a NO-releasing variant of PAN powder, applied after balloon angioplasty, decreased formation of scar tissue in the artery. "Many applications of this chemistry in vascular surgery and other medical procedures can be envisioned,” the authors wrote in their article. "Possible applications of these polymers include arterial stenting, bypass grafting, and surgical endarterectomy.”


Related Links:
U.S. National Cancer Institute
Northwestern University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.